| abstract |
THE INVENTION RELATES TO NEW 2-GUANIDINO-4-HETEROARYLTHIAZOLE WITH ACTIVITY AS ANTISEPRETORIC AGENTS AND HISTAMINE-H LOW-2 ANTAGONISTS, AND THEREFORE ARE NECESSARY FOR THE PREVENTION AND TREATMENT OF MAGNOBER CONTROL AND SELF-FLUORESCENT DISEASES. THE INVENTION METHOD FOR PRODUCING A CONNECTION OF THE GENERAL FORMULA (IB) AND THEIR PHARMACEUTICALLY ACCEPTABLE SAEUREADDITIONAL SALTS IS CHARACTERIZED BY USING A CONNECTION OF THE FORMULA (IIB) WITH A CONNECTION OF THE FORMULA RC (S) NH DEPTH 2 AND, IF SUCH, A CONNECTION OF FORMULA (IB) WITH EG CONVERTING AN ALKYL OR ARALKYL HALOGENIDE TO THE CORRESPONDING COMPOUND, AND, IF DESIRED, CONVERTING THE RECONNECTED CONNECTION OF THE FORMULA (IB) TO A PHARMACEUTICALLY ACCEPTABLE SALT. |